Use of immunohistochemical markers in clinical-morphological diagnostic of prostate diseases.

Authors

  • J. Grygorieva Clinical hospital Feofania Kyiv, Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2010.3.18-22

Keywords:

prostate, prostate cancer, diagnostic, prostate-specific antigen, pathomorphology, immunohistochemical markers

Abstract

High incidence and mortality rates of prostate cancer stipulate the necessity of new diagnostic approach development. The aim of investigation was the comparison of clinical and morphological methods of prostate disease patients examination and detection of necessity of immunohistochemical methods usage for optimisation of clinical-morphological diagnostic of prostate cancer. There were 169 patients of different age groups with prostate pathology that took part in the investigation. All of them were examined by serum prostate-specific antigen detection, digital rectal examination, transrectal ultrasound examination with transrectal needle biopsies, histological assessment and detection of AMACR and p63 (PIN coctail) expression. As a result of comparison the correlation between serum prostate specific antigen level and morphological changes in prostate tissue was developed. It was established that simultaneous usage of AMACR and p63 helps to differentiate cancer and pretumor conditions in difficult cases. So, to establish a correct diagnose and prognosis of disease it is necessary to use complex diagnostic approach.

References

  1. Возіанов О. Ф. Аналіз роботи Урологічної служби в Україні / О. Ф. Возіанов, С. П. Пасечніков // Урологія. – 2005. – Т. 9, № 1. – С. 5-9.
  2. Левицький Е. О. Сучасні алгоритми діагностики пухлин передміхурової залози: [монографія] / Е. О. Левицький. – Житомир : Полісся, 2007. – 320 с.
  3. Новиков Д. А. Статистические методы в медико-биологическом эксперименте (типовые случаи) / Д. А. Новиков, В. В. Новочадов // Волгоград : ВолГМУ, 2005. – 84 с.
  4. Пушкарь Д. Ю. Простатспецифический антиген и биопсия предстательной железы / Д. Ю. Пушкарь. – М. : МЕДпресс-информ. – 2003. – 160 с.
  5. Рекомендації Європейської Асоціації Урології / К. Абооу, П. Абрамс, Д. Акерман [та ін.] // 2005. – С. 14-22.
  6. Лапач С. Н. Статистика в науке и бизнесе / С. Н. Лапач, А. В. Чубенко, П. Н. Бабич. - Киев : Морион, 2002. – 640 с.
  7. Alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer / M. A. Rubin, M. Zhou, S. M. Dhanasekaran [et al.] // Jama. – 2002. – Vol. 287, № 13. – P. 1662-1670.
  8. Detection of AMACR (P504S), P63 and 34betaE12 cocktail in the early diagnosis of prostate cancer / T. Yu, S. X. Zhu, S. Zheng, S. P. Chen // Zhonghua Nan Ke Xue. – 2007. – Vol. 13, № 3. – P. 222-225.
  9. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? / M. Zhou, H. Aydin, H. Kanane, J. I. Epstein // Am. J. Surg. Pathol. – 2004. – Vol. 28, № 2. – P. 239-243
  10. Prevalence of prostate cancer among men with a prostatespecific antigen level < or = 4.0 ng per milliliter / I. M. Thompson, D. K. Pauler, P. J. Goodman [et al.] // N. Engl. J. Med. – 2004. – Vol. 350. – P. 2239 – 2246.
  11. Thompson С. А. Prostate-specific antigen in the early detection of prostate cancer / Ian M. Thompson, Donna P. Ankerst // CMAJ. – 2007. – Vol. 176, № 13. – P. 1853-1858.

How to Cite

Grygorieva, J. (2010). Use of immunohistochemical markers in clinical-morphological diagnostic of prostate diseases. Морфологія / Morphologia / Morfologìâ, 4(3), 18–22. https://doi.org/10.26641/1997-9665.2010.3.18-22

Issue

Section

Статті